Other and unspecified papulosquamous disorders

L12_PAPULOSQUONAS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L44.8, L44.9 Hospital discharge: ICD-9 — 697[8-9]\|6970 Hospital discharge: ICD-8 — 69799\|696[5-9] Cause of death: ICD-10 — L44.8, L44.9 Cause of death: ICD-9 — 697[8-9]\|6970 Cause of death: ICD-8 — 69799\|696[5-9] 2 out of 7 registries used, show all original rules.	213
4. Check minimum number of events None	213
5. Include endpoints None	213
6. Filter based on genotype QC (FinnGen only)	213

Control definitions (FinnGen only)

Control exclude: L12_PAPULOSQUAMOUS

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	L12_PAPULOSQUONAS
CONTROL_EXCLUDE	L12_PAPULOSQUAMOUS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L44[8-9]
HD_ICD_9	697[8-9]\|6970
HD_ICD_8	69799\|696[5-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L44[8-9]
COD_ICD_9	697[8-9]\|6970
COD_ICD_8	69799\|696[5-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified papulosquamous disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2302	1336	944
Only index persons	1746	1046	700
Unadjusted period prevalence (%)
Whole population	0.03	0.04	0.03
Only index persons	0.03	0.04	0.03
Median age at first event (years)
Whole population	44.89	48.49	39.61
Only index persons	39.20	43.78	32.35

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	213	123	90
Unadjusted period prevalence (%)	0.04	0.04	0.04
Median age at first event (years)	46.66	44.65	49.42

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
196: Matched controls
1959

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L44.8

ICD-10 Finland

Other specified papulosquamous disorders

+∞

76.1

6970A

ICD-9 Finland

Lichen planus[LICHEN RUBER PLANUS]

+∞

53.6

L44.9

ICD-10 Finland

Papulosquamous disorder, unspecified

643.0

52.0

D07AC01

ATC

betamethasone; topical

5.3

26.0

111

387

L40.0

ICD-10 Finland

Psoriasis vulgaris

246.4

22.1

D07XC01

ATC

betamethasone, combinations; topical

7.8

21.8

D05AX52

ATC

calcipotriol, combinations; topical

18.9

16.6

E0000UV

ATC

3.5

15.6

106

491

D05BB02

ATC

acitretin; oral

24.6

13.2

D07AB02

ATC

hydrocortisone butyrate; topical

3.4

13.0

339

D05AX02

ATC

calcipotriol; topical

13.7

12.5

E000001

ATC

3.8

12.4

205

D07AA02

ATC

hydrocortisone; topical

4.5

12.0

126

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.8

11.9

186

D07AC13

ATC

mometasone; topical

3.1

10.7

318

E000002

ATC

4.7

10.5

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

+∞

9.4

D07AB08

ATC

desonide; topical

4.1

8.8

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

+∞

8.4

L40.5

ICD-10 Finland

Arthropathic psoriasis

+∞

8.4

L43.8

ICD-10 Finland

Other lichen planus

34.9

8.2

D07AD01

ATC

clobetasol; topical

3.4

8.2

141

R06AE07

ATC

cetirizine; oral

2.4

7.8

547

D07BA04

ATC

hydrocortisone and antiseptics; topical

4.0

7.5

69698

ICD-8 Finland

Psoriasis and similar disorders, Other disorders

+∞

7.3

TQW80

NOMESCO Finland

Local dermatologic skincare

10.6

7.1

E000003

ATC

6.9

6.8

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.6

6.7

249

D07AB01

ATC

clobetasone; topical

7.3

6.7

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.6

6.5

103

Kela drug reimbursment

Diabetes, insulin-treated

2.4

6.3

310

69699

ICD-8 Finland

+∞

6.3

L40.8

ICD-10 Finland

Other psoriasis

+∞

6.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000570) Elastase.pancreatic [Mass/mass] in Stool

4.02

5.94

1.5

1.4

282.1

284.2

ug/g

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

104

701

1.95

5.35

2.8

2.3

76.3

nmol/l

0.00

623

(3027945) Reticulocytes/100 erythrocytes in Blood

181

2.41

5.29

5.8

2.9

1.8

1.7

0.21

162

(3000494) Fungus identified in Specimen by Culture

188

2.39

5.27

1.5

1.4

—

(3012544) pH of Venous blood

172

2.39

4.99

3.4

3.8

—

(3002032) Base excess in Venous blood by calculation

167

2.39

4.87

3.4

3.8

2.1

2.3

mmol/l

0.07

121

(3007853) Bacteria identified in Skin by Aerobe culture

169

2.36

4.75

2.3

1.7

—

(3000991) Gas panel - Venous blood

143

2.46

4.69

7.7

7.0

—

(3037522) Nuclear Ab [Titer] in Serum

199

2.24

4.61

1.5

1.4

213.3

503.4

titre

1.51

(3024561) Albumin [Mass/volume] in Serum or Plasma

102

725

1.78

4.12

7.0

4.5

35.4

35.8

g/l

0.39

683

(3052851) Hemolysis interference index of Serum or Plasma

3.58

3.97

3.4

3.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

280

1.97

3.92

2.8

2.1

11.6

13.0

umol/l

0.69

254

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

418

1.84

3.87

3.5

1.9

3.1

mg/l

0.03

360

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.61

3.86

3.3

4.0

24.1

24.4

mmol/l

0.13

(4062490)

6.21

3.86

1.2

1.1

—

(3023368) Bacteria identified in Blood by Culture

453

1.81

3.82

5.1

4.4

—

(3023520) Reticulocytes [#/volume] in Blood

132

2.29

3.65

3.3

2.7

71.9

67.7

e9/l

0.30

103

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

106

2.42

3.61

2.1

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

127

985

1.72

3.59

14.8

9.2

4.6

4.1

e9/l

1.15

111

852

(3019198) Lymphocytes [#/volume] in Blood

113

855

1.69

3.46

10.1

5.6

2.1

e9/l

0.07

102

759

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

660

1.69

3.43

2.5

1.9

107.1

95.5

pmol/l

1.01

334

(3013115) Eosinophils [#/volume] in Blood

113

861

1.67

3.32

10.8

5.7

0.2

e9/l

0.75

102

757

(3001604) Monocytes [#/volume] in Blood

110

836

1.65

3.24

10.1

5.6

0.6

e9/l

0.66

722

(3006315) Basophils [#/volume] in Blood

110

837

1.65

3.22

10.3

5.7

0.0

e9/l

0.40

724

(3000093) Morphology [Interpretation] in Blood Narrative

6.54

3.21

1.7

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

496

1.68

3.06

4.4

3.9

7.9

9.0

mg/mmol

0.11

307

(3011397) Hemoglobin [Presence] in Urine by Test strip

387

1.73

2.99

4.2

4.0

—

(3037756) Immunofixation for Serum or Plasma

3.26

2.97

1.5

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

110

849

1.61

2.96

7.3

6.1

1.2

mmol/l

0.38

719

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

6.82

2.88

3.0

1.6

969.2

943.2

u/ml

—

(3009508) Creatinine [Moles/volume] in Urine

503

1.65

2.88

4.0

3.2

6.5

7.5

mmol/l

1.65

426

(3007164) IgA [Mass/volume] in Serum or Plasma

346

1.71

2.72

2.8

1.4

2.6

2.3

g/l

0.42

190

(42870588) Differential panel, method unspecified - Blood

556

1.60

2.67

9.5

5.5

—

(40758558) Short blood count panel - Blood

442

1.64

2.65

10.8

7.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

100

776

1.54

2.50

7.3

5.4

1.2

mmol/l

0.43

710

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

132

2.01

2.48

2.3

3.3

106.6

70.5

ng/l

1.01

122

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

630

1.55

2.43

3.9

3.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.19

2.41

1.7

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.85

2.41

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

299

1.69

2.38

3.5

2.8

1.0

1.2

e6/l

0.23

169

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

6.37

2.38

1.8

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

6.37

2.38

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

6.37

2.38

1.8

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

6.37

2.38

1.8

2.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

283

1.70

2.37

1.3

30.8

42.0

iu/ml

0.26

(3019150) Specific gravity of Urine by Refractometry

376

1.62

2.35

4.7

4.3

1.0

kg/l

—

(3036489) Thrombin time

2.47

2.34

2.6

3.6

20.9

22.3

0.32

(3034770) Mitochondria Ab [Titer] in Serum

2.95

2.34

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

204

1.79

2.32

6.6

104.6

103.6

mmol/l

0.49

198

(3018010) Neutrophils/100 leukocytes in Blood

101

796

1.51

2.29

10.2

5.7

54.4

56.4

0.86

749

(3009261) Glucose [Presence] in Urine by Test strip

107

854

1.51

2.29

4.1

4.0

0.0

estimate

—

162

(3048689) Calprotectin [Mass/mass] in Stool

221

1.76

2.28

4.4

2.0

140.4

129.5

ug/g

0.10

174

(3022313) Gas panel - Capillary blood

2.22

2.25

4.9

3.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

183

1.81

2.23

2.0

2.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

5.66

2.22

1.0

1.6

16.0

13.9

umol/l

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

5.66

2.22

1.0

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

364

1.61

2.21

2.2

2.0

1.5

1.3

mg/l

0.31

284

(3019309) Folate [Moles/volume] in Red Blood Cells

305

1.65

2.21

1.8

1.7

1145.5

1215.3

nmol/l

0.22

225

(3017181) Myelocytes/100 leukocytes in Blood

140

1.89

2.12

6.0

4.0

3.0

0.9

—

(3035350) Ketones [Presence] in Urine by Test strip

105

845

1.48

2.10

4.1

3.9

0.0

estimate

—

167

(3037467) Urinalysis macro (dipstick) panel - Urine

136

1153

1.50

2.09

5.3

4.3

—

(4027681)

5.09

2.08

1.6

1.2

—

(40768797) Stomach Pathology biopsy report

219

1.72

2.08

1.4

1.2

—

(4010399)

126

1.93

2.08

1.7

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

293

1.63

2.07

1.7

1.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

260

1.66

2.07

2.5

1.9

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.58

2.04

2.5

2.6

—

(40768443) Skin Pathology biopsy report

2.27

1.99

1.6

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

174

1.77

1.99

2.3

1.7

—

(3012516) Albumin [Mass/volume] in Urine

470

1.52

1.98

3.9

3.1

53.0

329.6

mg/l

0.81

300

(3014148) Varicella zoster virus Ab [Titer] in Serum

4.63

1.95

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

4.63

1.95

3.2

2.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

107

1.96

1.94

4.8

2.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

1.91

0.0

1.5

—

248.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

274

1.61

1.90

3.8

3.1

3.6

3.0

e6/l

0.11

147

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

169

1.76

1.89

1.8

2.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

169

1.76

1.89

1.2

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2.93

1.88

1.3

1.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2.93

1.88

1.1

1.3

—

(3000492) Spirometry study

154

1.78

1.86

1.7

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

131

1.85

1.86

6.5

4.2

0.7

0.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

178

1.73

1.85

2.2

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

4.24

1.83

1.6

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.64

1.82

1.1

1.2

—

(4034850)

2.30

1.77

10.2

13.7

—

(3018095) Leukocytes [#/volume] in Urine

636

1.44

1.77

4.7

3.8

23.0

66.3

e6/l

2.37

455

(3045142) Bone marrow Pathology biopsy report

3.40

1.76

1.8

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

546

1.45

1.73

3.8

3.3

14.0

160.0

e6/l

0.68

425

(3026493) Urate [Moles/volume] in Serum or Plasma

411

1.49

1.72

3.9

2.7

380.6

4306.2

umol/l

1.31

346

(3021601) Nitrite [Presence] in Urine by Test strip

103

849

1.41

1.71

5.6

5.3

0.0

estimate

0.00

164

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

377

1.50

1.69

1.7

1.4

0.7

1.7

u/ml

0.88

(3042936) Bacteria identified in Isolate by Culture

232

1.61

1.68

2.6

1.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

3.22

1.67

1.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

258

1.58

1.66

2.3

30.8

29.4

0.44

250

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

487

1.45

1.64

3.5

3.0

830.0

1495.3

ng/l

1.76

409

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

146

1285

1.43

1.64

4.6

3.9

14.9

14.8

pmol/l

0.15

135

1159

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

167

1508

1.50

1.63

8.2

5.7

42.4

39.8

mmol/mol

1.96

160

1405

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1.89

1.63

1.2

99.2

133.9

iu/ml

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

174

1585

1.53

1.62

5.3

4.5

6.4

5.9

mmol/l

2.25

162

1449

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

184

1697

1.62

22.7

14.1

23.0

23.5

mg/l

0.07

149

1325

(3005322) IgE [Units/volume] in Serum or Plasma

1.92

1.61

1.5

1.2

154.0

134.0

u/ml

0.08

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2.27

1.60

1.6

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

2.34

1.55

1.0

1.8

204.8

286.1

mu/l

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

147

1301

1.42

1.55

10.8

7.2

83.2

80.4

u/l

0.31

140

1219

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

237

1.57

1.55

1.3

1.5

—

(3023410) Appearance of Cerebral spinal fluid

3.39

1.53

1.2

1.9

—

(3033658) Prothrombin time (PT) actual/Normal

403

1.46

1.52

5.3

3.8

92.4

90.9

0.16

397

(3013707) Erythrocyte sedimentation rate by Westergren method

142

1252

1.40

1.51

6.2

4.0

13.2

11.9

mm/h

0.54

133

1145

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.91

1.51

2.3

4.2

—

(36304419) Bacteria [Presence] in Urine

486

1.42

1.49

3.6

3.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2.43

1.47

1.9

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2.43

1.47

1.9

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.17

1.44

1.2

1.0

—

(3023419) Bacteria identified in Sputum by Culture

2.78

1.44

2.2

3.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.78

1.44

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2.78

1.44

1.0

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

434

1.43

1.44

1.8

1.6

20.0

21.2

nmol/l

0.23

370

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

107

907

1.36

1.42

7.6

6.1

11.3

11.9

umol/l

0.29

856

(3032080) INR in Blood by Coagulation assay

650

1.37

1.38

7.6

9.1

1.2

inr

0.05

201

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.99

1.36

1.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.99

1.36

1.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.99

1.36

1.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.99

1.36

1.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.99

1.36

1.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.99

1.36

1.0

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2.18

1.36

1.5

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

504

1.39

1.33

3.8

3.2

0.2

0.3

e6/l

0.60

382

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.14

1.32

1.7

1.6

—

(1002224) Polysomnography panel

1.99

1.30

1.0

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2.09

1.28

2.2

1.3

—

(3018418) pH of Serum or Plasma

526

1.37

1.27

4.8

3.7

7.4

—

(3020891) Body temperature

1.91

1.27

2.0

4.4

—

(3026782) Osmolality of Urine

345

1.43

1.26

3.1

3.0

524.2

551.8

mosm/kgh2o

0.38

305

(40760892) CBC W Ordered Manual Differential panel - Blood

372

1.41

1.26

7.2

5.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2.27

1.25

1.1

1.4

—

3.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

2.04

1.25

1.4

1.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

119

1039

1.33

1.24

3.4

3.0

—

(40768804) Tissue Pathology biopsy report

651

1.34

1.22

2.3

2.1

—

(44790047)

2.67

1.22

1.4

1.9

—

(44806118)

2.67

1.22

1.4

1.9

—

(44790048)

2.67

1.22

1.4

1.9

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

2.67

1.22

1.2

2.2

15.3

17.6

ug/l

—

(44790049)

2.67

1.22

1.4

1.9

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

134

1.63

1.19

2.7

2.6

75.8

63.1

ml/min/173m2

0.63

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

261

1.46

1.18

1.3

1.1

12.8

u/ml

2.54

105

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2.09

1.16

1.3

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

111

1.68

1.16

4.9

7.1

24.0

25.0

mmol/l

0.64

111

(1761868) Lipid panel - Serum or Plasma

557

0.71

1.16

3.4

2.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.90

1.16

7.3

2.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

2.53

1.15

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

534

1.34

1.15

3.8

2.5

56.0

57.9

u/l

0.17

499

(36660697) Celiac disease serology panel - Serum

144

1.59

1.14

1.3

1.2

—

(3009343) pH of Capillary blood

112

1.66

1.13

5.5

3.3

—

7.4

—

(3044640) Blood type and Crossmatch panel - Blood

517

1.34

1.12

3.4

2.3

—

(3026008) Bacteria identified in Urine by Culture

537

1.33

1.10

4.1

2.9

—

(40761536) Microorganisms panel - Urine sediment

149

0.52

1.08

3.9

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

2.16

1.06

1.0

1.4

—

47.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

114

1.63

1.06

5.5

3.2

5.3

5.1

kpa

0.64

105

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.00

1.05

1.4

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2.09

1.04

1.1

1.3

—

(3008898) HLA-B27 [Presence]

1.81

1.03

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

581

1.31

1.01

3.9

3.1

2.3

2.4

mmol/l

0.43

511

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2.03

1.01

1.6

1.5

60.3

107.7

e6/l

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

2.03

1.01

1.4

1.3

1.0

3.7

e6/l

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

167

1554

1.35

0.99

5.7

4.7

1.9

mu/l

0.16

156

1422

(3045424) Erythrocytes [Presence] in Urine

2.26

0.94

2.0

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2.10

0.90

1.0

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1.85

0.87

9.3

3.7

26.6

26.0

mg/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

163

1.46

0.86

1.7

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

1.96

0.85

8.8

4.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

170

1600

1.31

0.82

5.1

4.4

4.5

4.6

mmol/l

0.70

161

1472

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

316

1.33

0.82

5.3

3.5

513.2

185.4

ng/l

0.47

247

(3021879) Hepatitis B virus core Ab [Presence] in Serum

106

1.55

0.81

1.1

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

164

1539

1.29

0.79

18.3

13.3

86.0

81.0

ml/min/173m2

1.80

130

1259

(3003396) Base excess in Arterial blood by calculation

184

1.41

0.78

7.9

6.2

0.1

1.2

mmol/l

0.59

142

(3002385) Erythrocyte distribution width [Ratio]

156

1457

1.26

0.77

25.2

17.0

14.0

13.6

0.95

151

1434

(3019550) Sodium [Moles/volume] in Serum or Plasma

181

1723

1.34

0.76

23.4

16.1

139.5

139.8

mmol/l

0.85

176

1679

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

384

1.29

0.76

3.4

2.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

186

1778

1.36

0.76

15.2

10.0

27.2

24.5

u/l

1.49

181

1719

(3021788) Differential panel - Synovial fluid

2.11

0.75

1.6

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

2.11

0.75

1.4

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

660

1.24

0.74

4.4

4.1

—

(40761535) Cells panel - Urine sediment

143

1.44

0.73

4.1

3.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

331

1.30

0.72

1.8

1.6

—

(3022145) Colonoscopy Study observation

187

1.38

0.72

1.6

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.94

0.71

1.4

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

1.94

0.71

4.8

10.8

4.8

6.6

mmol/l

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

181

1728

1.32

0.70

23.5

16.1

4.0

mmol/l

0.16

176

1685

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.69

0.69

1.4

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.87

0.69

1.8

1.7

—

(3005033) Fetal Nuchal fold Thickness US

1.80

0.66

1.8

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.80

0.66

1.8

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.80

0.66

1.4

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1.61

0.66

10.4

3.7

149.9

191.2

mg/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

191

1.35

0.64

7.2

7.7

—

(3044290) Cell count panel - Cerebral spinal fluid

1.74

0.64

1.6

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.68

0.62

1.8

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.68

0.62

1.8

1.5

—

(3025941) Bacteria identified in Stool by Culture

1.47

0.60

1.6

1.2

—

(3021901) Oxygen saturation in Capillary blood

1.73

0.58

3.2

2.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.69

0.57

1.0

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.69

0.57

2.7

2.9

63.0

59.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.69

0.57

2.5

2.8

4.8

4.6

e9/l

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

637

1.20

0.57

4.1

4.0

22.1

36.6

ng/l

1.45

444

(3044889) 12 lead EKG panel

123

1141

1.18

0.56

3.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.50

0.54

3.1

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

477

1.21

0.53

4.9

4.2

0.0

estimate

—

159

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.47

0.53

2.8

3.1

1.1

1.3

0.28

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.42

0.52

3.4

2.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.51

0.52

1.0

1.3

—

(3021589) Normoblasts [#/volume] in Blood

769

1.18

0.52

11.0

10.3

0.0

e9/l

0.29

631

(3002256) Pathology report gross observation

199

0.74

0.49

1.7

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

166

1591

1.20

0.47

4.8

4.4

1.4

1.5

mmol/l

3.19

157

1455

(3007461) Platelets [#/volume] in Blood

193

1879

1.29

0.45

32.0

20.5

252.6

250.1

e9/l

0.19

184

1837

(3035941) MCH [Entitic mass]

193

1879

1.29

0.45

31.8

20.4

30.2

0.10

186

1856

(3024731) MCV [Entitic volume]

193

1879

1.29

0.45

31.9

20.4

91.0

90.9

0.14

186

1856

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.39

0.45

1.3

—

(3010813) Leukocytes [#/volume] in Blood

193

1880

1.28

0.44

32.1

20.5

7.3

6.8

e9/l

1.47

184

1826

(3026361) Erythrocytes [#/volume] in Blood

193

1880

1.28

0.44

32.1

20.5

4.5

e12/l

0.60

184

1831

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.43

0.44

15.1

6.4

—

(21494755) Public health laboratory ask at order entry panel

139

0.71

0.43

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.45

0.43

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.42

0.42

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.42

0.42

1.3

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.58

0.42

1.8

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.58

0.42

1.8

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.58

0.42

1.8

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.58

0.42

1.8

1.5

—

(3019060) Gas panel - Arterial blood

105

1.36

0.42

2.3

3.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

781

1.15

0.41

5.0

4.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.39

0.41

1.3

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

193

1883

1.27

0.41

32.1

20.5

135.4

134.8

g/l

0.21

187

1856

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.48

0.40

1.2

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.48

0.40

1.0

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.40

0.0

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.44

0.39

2.0

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1.36

0.37

3.6

4.4

4.8

5.0

kpa

—

(3012501) Base excess in Blood by calculation

1.36

0.37

3.6

4.4

0.7

2.4

mmol/l

—

(3027315) Oxygen [Partial pressure] in Blood

1.36

0.37

3.6

4.4

6.8

8.5

kpa

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1.48

0.36

1.7

1.6

58.8

324.4

pmol/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.44

0.36

1.3

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.37

0.34

1.2

1.3

—

(3013512) EKG study

493

0.86

0.34

4.5

3.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.67

0.33

1.3

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

101

1.31

0.32

1.2

1.3

—

34.4

—

(3000330) Specific gravity of Urine by Test strip

0.72

0.31

4.7

3.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.33

0.31

3.1

4.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.33

0.31

1.3

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.31

0.28

2.0

1.2

—

(3022621) pH of Urine by Test strip

120

0.74

0.28

2.9

2.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

168

1635

1.13

0.27

5.9

5.0

2.6

2.7

mmol/l

0.67

157

1495

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

379

1.13

0.26

3.6

4.6

26.8

21.1

0.66

185

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

264

1.16

0.26

1.5

1.3

—

(40761511) CBC panel - Blood by Automated count

181

1772

1.14

0.25

17.5

13.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

115

1101

1.10

0.24

4.4

2.9

54.0

42.9

u/l

0.72

108

1029

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

0.72

0.24

3.0

48.7

494.3

u/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1.26

0.22

5.4

4.8

12.6

31.7

mg/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.26

0.22

1.8

1.5

—

(3010421) pH of Blood

1.19

0.21

3.6

4.2

7.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

0.21

0.0

1.4

—

152.8

—

(3012441) Differential panel - Pleural fluid

0.00

0.21

0.0

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.21

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3017569) Oxygen content in Arterial blood

0.00

0.21

0.0

8.4

—

(40768441) Liver Pathology biopsy report

0.00

0.21

0.0

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.21

0.0

7.2

—

(44813793)

0.00

0.21

0.0

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

4.8

—

111.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.21

0.0

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.21

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

0.00

0.21

0.0

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1.26

0.20

6.2

2.2

23.8

25.7

mmol/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

157

1532

1.09

0.20

4.6

3.9

1.4

1.2

mmol/l

2.35

146

1397

(3045414) Leukocytes [Presence] in Urine

1.15

0.15

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

158

1550

1.07

0.14

24.1

14.2

39.1

39.9

0.49

115

1130

(3020564) Creatinine [Moles/volume] in Serum or Plasma

181

1788

1.08

0.11

25.1

16.3

75.5

76.0

umol/l

0.08

181

1788

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

144

1.12

0.10

2.9

2.4

8.7

5.3

ug/l

0.27

128

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.14

0.10

1.6

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.07

0.09

1.4

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.04

0.09

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

124

0.88

0.09

2.0

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.09

0.09

1.8

2.1

—

(3016879) Cocaine [Presence] in Urine

1.04

0.08

1.2

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.84

0.08

1.0

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.03

0.07

2.0

1.9

—

(3003694) ABO and Rh group [Type] in Blood

447

0.95

0.07

1.3

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

173

0.92

0.07

3.3

3.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.85

0.07

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

161

0.93

0.05

1.9

1.8

—

(3019225) pH of Specimen

151

1.06

0.03

3.7

3.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

280

1.04

0.03

2.4

3.0

0.7

0.8

ug/l

0.03

182

(4035726)

142

1.06

0.02

1.3

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

474

1.02

0.00

3.4

3.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

148

1.01

0.00

1.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.5

—

(3044007) Cell count panel - Peritoneal fluid

0.00

0.0

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.3

—

(3014271) Vancomycin [Susceptibility]

0.00

0.0

2.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

0.91

0.00

2.0

1.9

—

(3035880) pH of Pleural fluid

0.00

0.0

1.2

—

(44806420)

0.00

0.0

2.5

—

(3006462) Nitrate [Presence] in Urine

0.00

0.0

1.7

—

(3012565) Volume of 24 hour Urine

0.00

0.0

3.4

—

2050.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

5.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

0.00

0.0

2.0

—

(44806071)

0.00

0.0

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.0

1.1

—

(3018133) Calcium [Moles/volume] in Urine

0.00

0.0

4.2

—

3.6

—

(3045788) Cell count panel - Pleural fluid

0.00

0.0

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

0.0

4.0

—

32.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3049717) Cytology report of Urine Cyto stain

1.00

0.00

2.2

2.7

—

(3017704) Immunofixation for Urine

0.00

0.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

1.00

0.00

1.2

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.99

0.00

1.6

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.0

1.0

—

(3027944) Amphetamines [Presence] in Urine

0.97

0.00

1.2

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.0

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.0

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.0

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.01

0.00

2.3

2.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.0

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

6.5

—

(3028300) Cannabinoids [Presence] in Urine

0.98

0.00

1.2

1.3

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

17.1

—

(3027008) Opiates [Presence] in Urine

0.98

0.00

1.2

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_PAPULOSQUONAS and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_PAPULOSQUONAS	1.667 [1.17, 2.38]	0.005
Birth year	0.992 [0.98, 1.0]	0.063

During the follow-up period (1.1.1998 — 31.12.2019), 87 out of 566 females with L12_PAPULOSQUONAS died.

Males

Parameter	HR [95% CI]	p-value
L12_PAPULOSQUONAS	1.932 [1.32, 2.84]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.008

During the follow-up period (1.1.1998 — 31.12.2019), 88 out of 428 males with L12_PAPULOSQUONAS died.

Mortality risk

Mortality risk for people of age

years, who have L12_PAPULOSQUONAS.

N-year risk	Females	Males
1	0.115%	0.391%
5	0.836%	2.163%
10	2.197%	5.375%
15	4.318%	10.143%
20	7.431%	16.83%

Relationships between endpoints

↥

Index endpoint: L12_PAPULOSQUONAS – Other and unspecified papulosquamous disorders

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified papulosquamous disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints